HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerardo C Glikin Selected Research

Ganciclovir (Cytovene)

6/2022Therapeutic potential of the cytosine deaminase::uracil phosphoribosyl transferase/5-fluorocytosine suicide system for canine melanoma.
1/2021Particulate mediators of the bystander effect linked to suicide and interferon-β transgene expression in melanoma cells.
1/2020Proliferation index and pseudoprogression as predictors of the therapeutic efficacy of suicide gene therapy for canine melanoma.
11/2019Combination of cytokine-enhanced vaccine and chemo-gene therapy as surgery adjuvant treatments for spontaneous canine melanoma.
8/2018Combination of Suicide and Cytokine Gene Therapies as Surgery Adjuvant for Canine Mammary Carcinoma.
1/2018Mechanisms Enhancing the Cytotoxic Effects of Bleomycin plus Suicide or Interferon-β Gene Lipofection in Metastatic Human Melanoma Cells.
10/2011Cytokine-enhanced vaccine and interferon-β plus suicide gene as combined therapy for spontaneous canine sarcomas.
5/2004Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids.
1/2002Lipofection of early passages of cell cultures derived from murine adenocarcinomas: in vitro and ex vivo testing of the thymidine kinase/ganciclovir system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerardo C Glikin Research Topics

Disease

13Melanoma (Melanoma, Malignant)
06/2022 - 05/2004
9Neoplasms (Cancer)
01/2020 - 05/2004
2Adenocarcinoma
05/2004 - 01/2002
1Herpes Simplex
06/2022
1Inflammation (Inflammations)
01/2020
1Neoplasm Metastasis (Metastasis)
11/2019
1Carcinoma (Carcinomatosis)
08/2018
1Necrosis
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
10/2011
1Sarcoma (Soft Tissue Sarcoma)
10/2011

Drug/Important Bio-Agent (IBA)

11InterferonsIBA
01/2021 - 10/2011
9Thymidine KinaseIBA
06/2022 - 01/2002
9Ganciclovir (Cytovene)FDA LinkGeneric
06/2022 - 01/2002
7Bleomycin (Blenoxane)FDA LinkGeneric
06/2022 - 05/2013
5CytokinesIBA
11/2019 - 10/2011
4VaccinesIBA
11/2019 - 10/2011
4Interleukin-2 (IL2)IBA
11/2019 - 09/2014
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2019 - 06/2015
2LipidsIBA
11/2019 - 05/2013
1TransferasesIBA
06/2022
1Cytosine DeaminaseIBA
06/2022
1Cisplatin (Platino)FDA LinkGeneric
06/2022
1UracilIBA
06/2022
1AntigensIBA
05/2017
1EnzymesIBA
05/2017
1Proteasome InhibitorsIBA
01/2017
1Bortezomib (Velcade)FDA Link
01/2017
1GelatinIBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2015
1Interferon Type IIBA
05/2015
1Culture MediaIBA
05/2015
1VX (EDIM)IBA
09/2014
1Macrophage Colony-Stimulating FactorIBA
09/2014
1Cell ExtractsIBA
09/2014
1DNA (Deoxyribonucleic Acid)IBA
05/2013

Therapy/Procedure

9Therapeutics
06/2022 - 10/2011
3Injections
11/2019 - 10/2011
2Subcutaneous Injections
08/2018 - 10/2011
1Immunotherapy
01/2020
1Treatment Delay
11/2019
1Aftercare (After-Treatment)
01/2018